Albala

Bruce_Albala_Thumbnail
Investors Business Daily, November 17, 2023

Quest For Alzheimer’s Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning

"The real breakthrough everyone is looking for is adding another disease-modifier that's not an amyloid modifier. Decades ago, scientists believed it was impossible to repair and regenerate nerves. That's no longer true. But a key challenge remains: Can you slow the disease enough to allow the unaffected parts of the brain to take over and keep people functioning at their normal level?" (Bruce Albala)
Bruce_Albala_Thumbnail
Best Life, April 24, 2023

5 Early Warning Signs of Dementia: How to Recognize Them and What to Do

"While AD is the most common cause for progressive dementia, many of the non-progressing forms of cognitive impairment are often the result of treatable conditions such as depression, hypothyroidism, folate (vitamin B) deficiency, etc. Even some of the progressive dementias are due to other neurological conditions such as Parkinson's disease, which can be treated." (Bruce Albala)
Bruce_Albala_Thumbnail
Medical News Today, March 30, 2023

Higher magnesium intake linked to lower dementia risk

"The authors propose that the higher magnesium intake might have resulted in less chronic inflammation in these older women. These results should be viewed as preliminary at this time, especially for the smaller magnesium dietary subgroups" (Bruce Albala)
Bruce_Albala_Thumbnail
Medical News Today, February 17, 2023

Where is Alzheimer’s research headed to and why?

"One of the biggest challenges to advancing the development of treatments for Alzheimer’s disease has been in identifying, recruiting, and retaining the appropriate patients." (Bruce Albala)